Demand Forecast
Drill-down by category, sub-category, or SKU (p50 + p95 model)
SKU · AAAMH47902
Magnesium Glycinate Bisglycinate Haute dose 1422 mg + Vitamine B6 180 gélules Origine Angleterre (UK)
longtail
3P
MEDICAMENTS
Last 4 weeks demand
8
▼ 57.9% vs prev 4w
Year-over-year
DORMANT
SKU existed but sold 0 units same 4w last year
Current stock
2
≈ 1.3 weeks of cover
Unit price
MAD 270
avg of last 30 sells · latest 2026-05-07
AAAMH47902
History (last 52 weeks) and LightGBM p95-quantile forecast for the SKU.
Cutoff: 2026-06-08 · Total forecast: 140 units.
Actual
Forecast p50 (expected)
Forecast p95 (upper bound)
Price history
Weekly qty-weighted average (MAD) of every non-null price/cost column in the OrderBook for this SKU. Click a legend entry to hide/show a line.
Why this forecast?
Magnesium Glycinate Bisglycinate Haute dose 1422 mg + Vitamine B6 180 gélules Origine Angleterre (UK) · in the longtail cohort · last 4 weeks 8 units, trending down -57.9% · on-hand 2 units
Signals the model saw
- Cohort: longtail (574 days of history, 109 units sold over 52 weeks)
- Volatility (CV): 1.09 — moderate
- Recent trend: last 4w = 8 units · prev 4w = 19 units
- Stockouts (last 13 weeks): none — history is reliable
- Calendar events firing in forecast window: none
Model output
| Realistic (p50) — next week | 4.6 units |
| Realistic (p50) — next 4 weeks | 16.8 units |
| Realistic (p50) — next 3 months | 43.9 units |
| Optimistic (p95) — next week | 12.6 units |
| Optimistic (p95) — next 4 weeks (reorder target) | 50.1 units |
| Optimistic (p95) — next 3 months (quarterly PO target) | 140.4 units |
| Legacy μ/wk (reorder pipeline) | 3.4 |
| Revenue exposure — optimistic, 3 months | MAD 37.9K |